These were the five most popular Becker's ASC Review gastroenterology/endoscopy stories for August:
GI & Endoscopy
Want to fill your Twitter feed with other gastroenterologists? Here are five gastroenterologists sharing unique perspectives on the industry and life in general:
PvP Biologics is conducting the first in-human clinical trials for its celiac disease drug candidate Kuma062.
Here are the five most popular gastroenterology and endoscopy stories for the week of Aug. 30 to Sept. 5, 2018:
Research suggests up to 60 percent of inflammatory bowel disease patients are turning to alternative medicines to ease symptoms, and as a result, Boston-based Harvard Medical School's Adam Cheifetz, MD, said gastroenterologists should ensure patients are still taking prescribed therapies,…
Advertisement
The American Gastroenterological Association commended the U.S. Senate's passage of the 2019 Labor-HHS-Education Appropriations bill, which increased the National Institutes of Health's funding by $2 billion.
Fujifilm Corp. invested an undisclosed amount in Suono Bio to support the company's second-generation drug pipeline.
Eric Shapiro, MD is a gastroenterologist at University Hospitals of Cleveland.
Cantel Medical is leaving Little Falls, N.J., behind for Plymouth, Minn.
Miami-based Gastro Health closed its acquisition of Boynton Beach-based South Florida Gastroenterology Associates, rebranding the practice's several locations under the Gastro Health banner.